Niacin improved rigidity and bradykinesia in a Parkinson's disease patient but also caused unacceptable nightmares and skin rash - A case report

Nutritional Neuroscience

Volumn 8, Issue 5-6, 2005, Pages 327-329

  Alisky, Joseph Martin ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

Bradykinesia; Niacin; Parkinson's disease; Pharmacogenomics

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; AMFEBUTAMONE; CARBIDOPA PLUS LEVODOPA; NICOTINIC ACID; SELEGILINE;

AGED; ARTICLE; BRADYKINESIA; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ERUPTION; DRUG TOLERABILITY; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; NIGHTMARE; PARKINSON DISEASE; PHARMACOGENOMICS; PRIORITY JOURNAL; PRURITUS; RASH; RIGIDITY; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; DREAMS; EXANTHEMA; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOKINESIA; MALE; MOTIVATION; MUSCLE RIGIDITY; NIACIN; PARKINSON DISEASE;

EID: 33646112393     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1080/10284150500484638     Document Type: Article

References (10)

1. Abbott, RD and Ross, GW and White, LR and Sanderson, WT and Burchfiel, CM and Kashon, M and Sharp, DS and Masaki, KH and Curb, JD and Petrovich, H. (2003) Environmental, life-style, and physical precursors of clinical Parkinson's disease: Recent findings from the Honolulu-Asia aging study J Neurol, 250(Supplement 3), pp. III30-III39.
2. Arwert, LI and Deijen, JB and Drent, ML. (2003) Effects of an oral mixture containing glycine, glutamine, and niacin on memory, GH and IGF-I secretion in middle-aged and elderly subjects Nutr Neurosci, 6, pp. 269-275.
3. Bender, DA and Earl, CJ and Lees, AJ. (1979) Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa Clin Sci (Lond), 56, pp. 89-93.
4. Cervantes-Laurean, D and McElvaney, NG and Moss, J.(1999) Niacin. In Modern nutrition in health and disease. (pp. 401-411). Baltimore, Maryland: Lippincott Williams and Wilkins.
5. Covault, J and Pettinati, H and Moak, D and Mueller, T and Kranzler, HR. (2004) Association of a long-chain fatty acid-CoA ligase 4 gene polymorphism with depression and with enhanced niacin-induced dermal erythema Am J Med Genet B Neuropsychiatr Genet, 127, pp. 42-47.
6. Fall, PA and Fredrikson, M and Axelson, O and Granerus, AK. (1999) Nutritional and occupational factors influencing the risk of Parkinson's disease: A case-control study in southwestern Sweden Mov Disord, 14, pp. 28-37.
7. Hellenbrand, W and Boeing, H and Robra, BP and Seidler, A and Vieregge, P and Nischan, P and Joerg, J and Oertel, WH and Schneider, E and Ulm, G. (1996) Diet and Parkinson's disease II: A possible role for the past intake of specific nutrients: Results from a self-administered food-frequency questionnaire in a case-control study Neurology, 47, pp. 644-650.
8. Hershey, T and Black, KJ and Carl, JL and McGee-Minnich, L and Snyder, AZ and Perlmutter, JS. (2003) Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease J Neurol Neurosurg Psychiatry, 74, pp. 844-851.
9. Petrie, WM and Ban, TA. (1985) Vitamins in psychiatry. Do they have a role? Drugs, 30, pp. 58-65.
10. Ross, GW and Abbott, RD and Petrovitch, H and Morens, DM and Grandinetti, A and Tung, KH and Tanner, CM and Masaki, KH and Blanchette, PL and Curb, JD and Popper, JS and White, LR. (2000) Association of coffee and caffeine intake with the risk of Parkinson disease JAMA, 283, pp. 2674-2679.